The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes
Open accessAbstract
OBJECTIVE: The liver-secreted protein fetuin-A induces insulin resistance in animals, and circulating fetuin-A is elevated in insulin resistance and fatty liver in humans. We investigated whether plasma fetuin-A levels predict the incidence of type 2 diabetes in a large prospective, population-based study. RESEARCH DESIGN AND METHODS: A case-cohort study within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study comprising 27,548 subjects was designed. We randomly selected a subcohort of 2,500 individuals of whom 2,164 were diabetes free at baseline and had anamnestic, anthropometrical, and metabolic data for analysis. Of the 849 incident diabetic case subjects identified in the full cohort during 7 years of follow-up, 703 remained for analyses after similar exclusions. RESULTS: Plasma fetuin-A levels were positively associated with diabetes risk after adjustment for age (relative risk [RR] for extreme quintiles 1.75 [95% CI 1.32-2.31]; RR for 10 mug/ml 1.04 [1.03-1.06]). The association remained significant after adjustment for sex, BMI, waist circumference, and lifestyle risk factors (RR for 10 mug/ml 1.03 [1.01-1.06]). Adjustment for glucose, triglycerides, HDL cholesterol, A1C, gamma-glutamyltransferase, or high-sensitivity C-reactive protein or mutual adjustment for these biomarkers did not appreciably change this result (RR for 10 mug/ml full adjusted model 1.05 [1.02-1.07]). Furthermore, fetuin-A was associated with increased diabetes risk particularly in individuals with elevated plasma glucose. CONCLUSIONS: Our data suggest that fetuin-A is an independent risk factor of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Notably, its levels have been found increased in obesity, especially associated with NAFLD [137], and are predictive for the development of T2DM [190].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Type 2 diabetes: principles of pathogenesis and therapy
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J. E., Carnes, B. A., Brody, J. A., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000167407.83915.e7 · Cited by 1,947
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,658
A Case-Cohort Design for Epidemiologic Cohort Studies and Disease Prevention Trials
Prentice, R. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.1 · Cited by 1,444
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,138
Adiponectin and protection against type 2 diabetes mellitus
Spranger, J., Kroke, A., Möhlig, M., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12255-6 · Cited by 1,120
Self-citation
Cited by
Sorted by citations
Items 201–300 of 379
Fasting plasma glucose and Type 2 diabetes risk: a non‐linear relationship
Schulze, M. B., Fritsche, A., Boeing, H., & Joost, H. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02919.x · Cited by 21
Self-citationMagalhães, P., Zürbig, P., Mischak, H., & Schleicher, E. D. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa176 · Cited by 21
Wang, Y., Koh, W., Jensen, M. K., Yuan, J., & Pan, A. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0171 · Cited by 20
Serum Fetuin-A levels in women with polycystic ovary syndrome
Gülhan, İ., Bozkaya, G., Öztekin, D. C., Uyar, İ., Kebapçılar, A. G., & Pamuk, B. Ö. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2494-0 · Cited by 21
Blumenthal, J. B., Gitterman, A., Ryan, A. S., & Prior, S. J. (2017) · Journal of Diabetes Research · doi:10.1155/2017/1492581 · Cited by 20
Schulze, M. B., & Hu, F. B. (2013) · Springer eBooks · doi:10.1007/978-0-387-09834-0_66 · Cited by 20
Self-citationBrandenburg, V. M., Jahnen‐Dechent, W., & Ketteler, M. (2009) · Kidney International · doi:10.1038/ki.2009.404 · Cited by 20
Fetuin-A and its genetic association with cardiometabolic disease
Ali, L. A., van de Vegte, Y. J., Said, M. A., Groot, H. E., Hendriks, T., Yeung, M. W., Lipšic, E., & van der Harst, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-48600-9 · Cited by 20
New and Emerging Biomarkers in Cardiovascular Disease
Cahill, L. E., Bertoia, M. L., Aroner, S. A., Mukamal, K. J., & Jensen, M. K. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0661-y · Cited by 20
Huang, H., Yeh, C., Chen, J., Lee, T.-H., Chen, S.-C., Lee, W., & Chen, C.-Y. (2018) · PeerJ · doi:10.7717/peerj.4884 · Cited by 19
Association of Fetuin-A Level and Diabetes Risk
Stefan, N. (2008) · JAMA · doi:10.1001/jama.2008.614 · Cited by 19
Self-citationJensen, M. K., Jensen, R. A., Mukamal, K. J., Guo, X., Yao, J., Sun, Q., Cornelis, M. C., Liu, Y., Chen, M., Kizer, J. R., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx091 · Cited by 18
Serum fetuin-A levels in obese and non-obese subjects with and without type 2 diabetes mellitus
Zhou, Z., Ju, H., Sun, M., Chen, H., Fu, Q.-P., & Jiang, D. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.023 · Cited by 19
Kiseleva, E. V., & Demidova, T. Y. (2021) · Obesity and metabolism · doi:10.14341/omet12758 · Cited by 17
Arregui, M., Buijsse, B., Stefan, N., Corella, D., Fisher, E., di Giuseppe, R., Coltell, Ó., Knüppel, S., Aleksandrova, K., Joost, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048338 · Cited by 16
Self-citationElevated serum fetuin-A levels are associated with grades of retinopathy in type 2 diabetic patients
Yılmaz, A., Yılmaz, T., & Günay, M. (2017) · International Ophthalmology · doi:10.1007/s10792-017-0750-9 · Cited by 16
Circulating levels of fetuin-A are associated with moderate–severe hepatic steatosis in young adults
Filardi, T., Panimolle, F., Tiberti, C., Crescioli, C., Lenzi, A., Pallotta, N., & Morano, S. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01274-w · Cited by 16
Prada, M., Wittenbecher, C., Eichelmann, F., Wernitz, A., Kuxhaus, O., Kröger, J., Weikert, C., & Schulze, M. B. (2022) · Diabetes Care · doi:10.2337/dc21-1897 · Cited by 15
Self-citationÖncü, K., Yazgan, Y., Tanoğlu, A., Kaplan, M., Ermış, F., İpçioğlu, O. M., Kara, M., Küçük, İ., & Özarı, H. O. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2814-7 · Cited by 15
Başar, N., Şen, N., Kanat, S., Özlü, M. F., Özcan, F., Çay, S., Erden, G., Cagli, K. E., Yıldırımkaya, M., Maden, O., et al. (2011) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318214b578 · Cited by 14
Genetic variants including markers from the exome chip and metabolite traits of type 2 diabetes
Jäger, S., Wahl, S., Kröger, J., Sharma, S., Hoffmann, P., Floegel, A., Pischon, T., Prehn, C. P., Adamski, J., Müller‐Nurasyid, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06158-3 · Cited by 14
Self-citationHepatokines, bile acids and ketone bodies are novel Hormones regulating energy homeostasis
Garruti, G., Baj, J., Cignarelli, A., Perrini, S., & Giorgino, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1154561 · Cited by 15
Gender dimorphism in regulation of plasma proteins in streptozotocin‐induced diabetic rats
Choi, J., Aseer, K. R., Chaudhari, H. N., Mukherjee, R., Choi, M., & Yun, J. W. (2013) · PROTEOMICS · doi:10.1002/pmic.201200529 · Cited by 14
Helicobacter pylori infection and fatty liver
Sarsenbaeva, A. S., Уфимцев, К. А., & Домрачева, Е. В. (2020) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-178-6-146-153 · Cited by 13
Cardiovascular risk in chronic kidney disease: what is new in the pathogenesis and treatment?
Bielach-Bazyluk, A., Małyszko, J., & Zbroch, E. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1481714 · Cited by 14
First-trimester irisin and fetuin-A concentration in predicting macrosomia
Zbucka-Krętowska, M., Kuźmicki, M., Telejko, B., Gościk, J., Ciborowski, M., Lipińska, D., Hryniewicka, J., Citko, A., Ławicki, S., & Wołczyński, S. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1450859 · Cited by 13
Hwang, J. J., Thakkar, B., Chamberland, J. P., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.02.006 · Cited by 13
Mühlenbruch, K., Kuxhaus, O., di Giuseppe, R., Boeing, H., Weikert, C., & Schulze, M. B. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.12.019 · Cited by 13
Self-citationAleman, J., Ravikumar, K., Wiegand, C., Schurdak, M. E., Vernetti, L. A., Gavlock, D. C., Reese, C. E., DeBiasio, R., LaRocca, G., Angarita, Y. D., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-07006-7 · Cited by 12
Joosten, M. M., Schrieks, I. C., & Hendriks, H. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-24 · Cited by 12
Lim, J. Y., & Kim, E. (2023) · Metabolites · doi:10.3390/metabo13090979 · Cited by 13
Association of Human Fetuin-A rs4917 Polymorphism with Obesity in 2 Cohorts
Temesszentandrási, G., Vörös, K., Böröcz, Z., Kaszás, E., Prohászka, Z., Falus, A., Cseh, K., & Kalabay, L. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000151 · Cited by 12
Fetuin-A levels in hyperthyroidism
Pamuk, B. Ö., Yilmaz, H., Topcuoglu, T., Bilgir, O., Çalan, Ö. G., Pamuk, G., & Ertuğrul, D. T. (2013) · Clinics · doi:10.6061/clinics/2013(03)oa15 · Cited by 12
Association between dietary factors and plasma fetuin-A concentrations in the general population
Nimptsch, K., Janke, J., Pischon, T., & Linseisen, J. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002639 · Cited by 12
Caillot, N., Bouley, J., Jain, K., Mariano, S., Luce, S., Horiot, S., Airouche, S., Beuraud, C., Beauvallet, C., Devillier, P., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.10.036 · Cited by 12
Fetuin-A level in type 2 diabetic patients: relation to microvascular complications
Al-Said, N. H., Taha, F., Abdelaziz, G. M., & Abdel-Tawab, M. S. (2018) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_24_18 · Cited by 12
Jäger, S., Cuadrat, R. R. C., Wittenbecher, C., Floegel, A., Hoffmann, P., Prehn, C. P., Adamski, J., Pischon, T., & Schulze, M. B. (2020) · Nutrients · doi:10.3390/nu12123890 · Cited by 13
Self-citationDadej, D., Szczepanek‐Parulska, E., & Ruchała, M. (2022) · Metabolites · doi:10.3390/metabo12040300 · Cited by 15
Kowall, B., Rathmann, W., Giani, G., Schipf, S., Baumeister, S. E., Wallaschofski, H., Nauck, M. A., & Völzke, H. (2012) · Primary care diabetes · doi:10.1016/j.pcd.2012.12.001 · Cited by 10
The impact of Ramadan fasting on Fetuin-A level in type 2 diabetes mellitus
Harbuwono, D. S., Sazli, B. I., Kurniawan, F., Darmowidjojo, B., Koesnoe, S., & Tahapary, D. L. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06773 · Cited by 12
Zhou, Z., Ju, H., Sun, M., Chen, H., Ji, H., Jiang, D., Ji, Y., & Ji, J. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0152 · Cited by 11
Fetuin-A serum levels in patients with aortic aneurysms of Marfan syndrome and atherosclerosis
Szeberin, Z., Fehérvári, M., Krepuska, M., Apor, A., Rimely, E., Sarkadi, H., Bíró, G., Sótonyi, P., Széplaki, G., Szabolcs, Z., et al. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02393.x · Cited by 11
Maharem, D. A., Gomaa, S. H., Ghandor, M. K. E., Mohamed, E. I., Matrawy, K. A., Zaytoun, S., & Nomeir, H. M. (2013) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2013.07.003 · Cited by 11
Relation of Serum and Vitreous Concentrations of Fetuin-A with Diabetic Retinopathy
Jiang, R. (2015) · Medical Science Monitor · doi:10.12659/msm.893403 · Cited by 11
Emerging Biomarkers and Nanobiosensing Strategies in Diabetes
Baranwal, A., Bansal, V., & Shukla, R. (2025) · Biosensors · doi:10.3390/bios15100639 · Cited by 14
Chuang, G., Kremer, D., Huang, C.-H., Alkaff, F. F., Lin, C., Tseng, T., Laverman, G. D., Bakker, S. J. L., & Chuang, L. (2023) · American Journal of Nephrology · doi:10.1159/000534514 · Cited by 10
Similarities and Differences of Vascular Calcification in Diabetes and Chronic Kidney Disease
Wang, X., Wang, Z., & He, J. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s438618 · Cited by 12
Márkus, B., Veszeli, N., Temesszentandrási, G., Farkas, H., & Kalabay, L. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-0995-7 · Cited by 10
Kovářová, M., Kalbacher, H., Peter, A., Häring, H., Didangelos, T., Stefan, N., Birkenfeld, A. L., Schleicher, E. D., & Kantartzis, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030411 · Cited by 11
Self-citationIndependent Dose–Response Associations between Fetuin-A and Lean Nonalcoholic Fatty Liver Disease
Lu, C., Lee, Y.-C., Chiang, C., Chang, H., Yang, W., & Huang, K. (2021) · Nutrients · doi:10.3390/nu13092928 · Cited by 10
Ren, G., Bowers, R. L., Kim, T., Araya-Ramírez, F., Mahurin, A. J., Dean, D. M., Grandjean, P. W., & Mathews, S. T. (2020) · Obesity · doi:10.1002/oby.22730 · Cited by 10
Positive Correlation between Circulating Fetuin-A and Severity of Coronary Artery Disease in Men
Afrisham, R., Paknejad, M., Ilbeigi, D., Sadegh‐Nejadi, S., Gorgani‐Firuzjaee, S., & Vahidi, M. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200601164253 · Cited by 9
Mass spectrometry for the study of adipocyte cell secretome in cardiovascular diseases
Gianazza, E., Brioschi, M., Eligini, S., & Banfi, C. (2022) · Mass Spectrometry Reviews · doi:10.1002/mas.21812 · Cited by 9
Suemanotham, N., Photcharatinnakorn, P., Chantong, B., Buranasinsup, S., Phochantachinda, S., Sakcamduang, W., Reamtong, O., Thiangtrongjit, T., & Chatchaisak, D. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.1057972 · Cited by 9
Topsakal, Ş., Akın, F., Turgut, S., Yaylalı, G. F., Herek, D., & Ayada, C. (2014) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563214562431 · Cited by 9
Circulating Fetuin-A and Risk of Ischemic Stroke in Women
Jiménez, M. C., Sun, Q., Schürks, M., Hu, F. B., Manson, J. E., & Rexrode, K. M. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.212597 · Cited by 9
Fetuina A u szczupłych i otyłych kobiet z zespołem policystycznych jajników
Kozakowski, J., Jeske, W., & Zgliczyński, W. (2014) · Endokrynologia Polska · doi:10.5603/ep.2014.0051 · Cited by 9
Temesszentandrási, G., Vörös, K., Márkus, B., Böröcz, Z., Kaszás, E., Prohászka, Z., Falus, A., Cseh, K., & Kalabay, L. (2016) · Medical Science Monitor · doi:10.12659/msm.896232 · Cited by 9
Serum Fetuin-A and Adipsin Levels in Type II Diabetes Patients
Karajibani, M., Montazerifar, F., Sadeghi, M. B., Kaykhaei, M. A., & Dashipour, A. (2019) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.91963 · Cited by 10
Fetuin-A and type II diabetes mellitus
Ahmed, L. I., Mousa, S. G., Mohamed, N. A. E.-G., Yousry, Z. A., & Khalaa, M. R. A.-E. (2014) · The Egyptian Journal of Internal Medicine · doi:10.4103/1110-7782.148140 · Cited by 8
Ramadan, A., Shoukry, A., Ismail, M. I., & Borai, M. (2011) · Cited by 8
Association between the development of diabetic foot and serum fetuin‑A levels
Özenç, S., Şimşek, K., Yıldırım, A. O., Arslan, E., Sarı, S., Ince, M., Sarı, O., Yeşilkaya, Ş., Aydoğan, Ü., Yaman, H., et al. (2013) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.1921 · Cited by 8
Lipocalin 13 enhances insulin secretion but is dispensable for systemic metabolic control
Bühler, L., Maida, A., Vogl, E. S., Georgiadi, A., Takacs, A., Kluth, O., Schürmann, A., Feuchtinger, A., von Toerne, C., Tsokanos, F., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202000898 · Cited by 9
Susairaj, P., Snehalatha, C., Nanditha, A., Satheesh, K., Raghavan, A., Vinitha, R., & Ramachandran, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-99784-x · Cited by 8
Wu, P., Wang, Y., Ye, Y., Yang, X., Lu, Q., Yuan, J., Zha, L., Liu, Y., Song, X., Yan, S., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac335 · Cited by 7
Association of Aquaporin 7 and 9 with Obesity and Fatty Liver in db/db Mice
Hirako, S., Wakayama, Y., Kim, H., Iizuka, Y., Wada, N., Kaibara, N., Okabe, M., Arata, S., & Matsumoto, A. (2023) · ZOOLOGICAL SCIENCE · doi:10.2108/zs230037 · Cited by 9
Komsa‐Penkova, R., Kovacheva, K., Golemanov, G. M., Penkov, V. P., Radionova, Z. V., Georgieva, G. A., & Izmajlov, A. V. (2018) · Journal of Biomedical and Clinical Research · doi:10.2478/jbcr-2018-0002 · Cited by 8
Multiomics Picture of Obesity in Young Adults
Kiseleva, O. I., Pyatnitskiy, M. A., Arzumanian, V. A., Kurbatov, I. Y., Ilinsky, V. V., Ilgisonis, E. V., Plotnikova, O. A., KhKh, S., Tutelyan, V. A., Nikityuk, D. B., et al. (2024) · Biology · doi:10.3390/biology13040272 · Cited by 7
Li, M., Tian, M., Wang, Y., Ma, H., Zhou, Y., Jiang, X., & Liu, Y. (2023) · Endokrynologia Polska · doi:10.5603/ep.96300 · Cited by 7
Role of ectopic fat in the pathogenesis of insulin resistance
Kantartzis, K., Totsikas, C., Häring, H., & Stefan, N. (2009) · Clinical Lipidology · doi:10.2217/clp.09.35 · Cited by 7
Self-citationShidfar, F., Zarrati, M., Khamseh, M. E., Haghighat, N., Rostami, A., & Zolfaghari, H. (2014) · PubMed Central · Cited by 7
Ren, G., Bowers, R. L., Kim, T., Mahurin, A. J., Grandjean, P. W., & Mathews, S. T. (2021) · Physiological Reports · doi:10.14814/phy2.14773 · Cited by 6
Umapathy, D., Subramanyam, P. V., Krishnamoorthy, E., Viswanathan, V., & Ramkumar, K. M. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108074 · Cited by 7
Liu, Y., Xu, M., Xu, Y., Li, M., Wang, T., Chen, Y., & Bi, Y. (2012) · Journal of Diabetes · doi:10.1111/1753-0407.12000 · Cited by 7
Elevated Fetuin - A Level Associated with an Atherogenic Lipid Profile in Type 2 Diabetes
Khalil, H. (2013) · Cited by 7
Reduced Serum Fetuin-A in Nephrotic Children: A Consequence of Proteinuria?
Fischer, D., Schaible, J., Wigger, M., Staude, H., Drückler, E., Kundt, G., & Haffner, D. (2011) · American Journal of Nephrology · doi:10.1159/000331061 · Cited by 7
Eswar, S., Rajagopalan, B., Ete, K., & Gattem, S. N. R. (2024) · JMA Journal · doi:10.31662/jmaj.2024-0104 · Cited by 6
A collagen-based laboratory model to mimic sex-specific features of calcific aortic valve disease
Allgayer, R., Kabir, R., Bergeron, A., Demers, P., Mantovani, D., & Cerruti, M. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.01.034 · Cited by 5
Pathak, A. K., Tiwari, V., Kulshrestha, M. R., Singh, S., Singh, S., & Singh, V. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01193-6 · Cited by 6
Eroglu, B., Eichelmann, F., Kuxhausf, O., Kipp, A. P., Schwerdtle, T., Haase, H., Schomburg, L., & Schulze, M. B. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02861-y · Cited by 7
Self-citationIndividualisierte Prävention des Typ-2-Diabetes
Stefan, N., Fritsche, A., & Häring, H. (2009) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-009-0868-7 · Cited by 6
Self-citationMoustafa, S. R. (2015) · AFMN Biomedicine · doi:10.1515/afmnai-2016-0020 · Cited by 6
Tseng, F., Chen, Y.-T., Chi, Y., Chen, P., & Yang, W. (2018) · Medicine · doi:10.1097/md.0000000000013254 · Cited by 6
Interaction of fetuin-A with obesity related insulin resistance and diabetes mellitus
Öner-İyidoğan, Y., & Koçak, H. (2024) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2024-0235 · Cited by 6
Koch, M., Jacobs, G., Hampe, J., Rosenstiel, P. C., Krawczak, M., & Nöthlings, U. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0078 · Cited by 5
Proteome changes in rat plasma in response to sibutramine
Choi, J. W., Joo, J. I., Kim, D. H., Wang, X., Oh, T. S., Choi, D. K., & Yun, J. W. (2011) · PROTEOMICS · doi:10.1002/pmic.201000664 · Cited by 5
Lowering effect of valsartan on fetuin-A in type 1 diabetes mellitus.
Gheissari, A., Javanmard, S. H., Shirzadi, R., Amini, M., & Khalili, N. (2013) · Iranian Journal of Kidney Diseases · Cited by 5
Association of fetuin-A with kidney disease; a review on current concepts and new data
Akbari, M., Nayeri, H., & Nasri, H. (2018) · Journal of Nephropharmacology · doi:10.15171/npj.2019.14 · Cited by 5
Underestimated Prediabetic Biomarkers: Are We Blind to Their Strategy?
Luís, C., Soares, R. A., Baylina, P., & Fernandes, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.805837 · Cited by 5
Márkus, B., Vörös, K., Supák, D., Melczer, Z., Cseh, K., & Kalabay, L. (2017) · PPAR Research · doi:10.1155/2017/7636019 · Cited by 5
The role of hepatokines in NAFLD-related extrahepatic diseases: culprit or accomplice?
Jiang, R., & Yang, L. (2017) · Gut · doi:10.1136/gutjnl-2017-314411 · Cited by 5
MASLD and the cardiovascular-kidney-liver-metabolic syndrome
Angelidi, A. M., Boutari, C., Kokkorakis, M., Stefanakis, K., Mikhailidis, D. P., Jacob, G., & Mantzoros, C. S. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag023 · Cited by 6
Hepatokines fetuin A and fetuin B status in women with/without gestational diabetes mellitus.
Yakout, S. M., Hussein, S., Al-Attas, O. S., Hussain, S. D., Saadawy, G. M., & Al‐Daghri, N. M. (2023) · PubMed Central · Cited by 4
Reinauer, C., Reinehr, T., Bächle, C., Karges, B., Seyfarth, J., Foertsch, K., Schebek, M., Woelfle, J., Roden, M., Holl, R. W., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000484896 · Cited by 5
Schulze, M. B., & Hu, F. B. (2022) · Springer eBooks · doi:10.1007/978-1-4614-6625-3_66-1 · Cited by 5
Self-citationMCP-1 and fetuin A levels in patients with PCOS and/or obesity before and after metformin treatment
Gateva, A., Kamenov, Z. A., & Tsakova, A. D. (2013) · Open Medicine · doi:10.2478/s11536-012-0149-y · Cited by 4
Mechanism of Lipid Induced Insulin Resistance: An Overview
Bhattacharya, S., Kundu, R., Dasgupta, S., & Bhattacharya, S. (2012) · Endocrinology and Metabolism · doi:10.3803/enm.2012.27.1.12 · Cited by 5
Mohamed, A. K., Abdallah, A. M., Hassan, M. A., Mohamed, N., & Kamel, S. A. (2013) · The Egyptian Journal of Internal Medicine · doi:10.4103/1110-7782.124996 · Cited by 4
Relationship between serum Fetuin-A and insulin resistance in patients with hyperthyroidism
Ammar, S., Elbedewy, T. A. E., Nagy, H., & Kotb, N. A. (2017) · Tanta Medical Journal · doi:10.4103/tmj.tmj_4_17 · Cited by 4
Electrochemical biosensors for enhanced detection of diabetes mellitus
Zhi, Y., Xie, S., & Wei, B. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120221 · Cited by 3
Metadata
- Authors
- Stefan, N., Fritsche, A., Weikert, C., Boeing, H., Joost, H.-G., Häring, H.-U., & Schulze, M. B.
- Affiliations
- University of Tübingen (DE)
- German Institute of Human Nutrition (DE)
- Department of Internal Medicine, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University of Tübingen, Tübingen, Germany
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-10-01
- Volume
- 57
- Issue
- 10
- Pages
- 2762-2767
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2551687
- OpenAlex
- W2130626015
- Cited by
- 379
- References
- 32
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 15 · 2023: 14 · 2022: 15 · 2021: 13 · 2020: 18 · 2019: 13 · 2018: 26 · 2017: 26 · 2016: 26 · 2015: 31 · 2014: 28 · 2013: 34 · 2012: 28
- FWCI
- 17.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Deutsche Krebshilfe
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- fetuin-A, type 2 diabetes, diabetes risk, insulin resistance, plasma biomarkers, hyperglycemia, EPIC-Potsdam cohort
- MeSH terms
- Adult, Age Factors, Aged, Blood Proteins, Diabetes Mellitus, Type 2, Female, Germany, Humans, Life Style, Male, Middle Aged, Risk Factors, Cohort Studies, alpha-2-HS-Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review